https://thevitalrecord.ai/2026/06/10/maple-hcm-aficamten-metoprolol/ The Vital Record en 2026-06-10T00:00:00.000Z Aficamten Beats Metoprolol on Exercise Capacity in Phase 3 Head-to-Head Trial for Obstructive HCM https://thevitalrecord.ai/2026/06/10/a-first-line-challenger-maple-hcm-analysis/ The Vital Record en 2026-06-10T00:00:00.000Z A First-Line Challenger: What MAPLE-HCM Means for the Clinic https://thevitalrecord.ai/2026/06/10/islend-once-weekly-hiv-phase3-primary-endpoints/ The Vital Record en 2026-06-10T00:00:00.000Z Investigational Once-Weekly HIV Pill Meets Primary Endpoints in Both Phase 3 ISLEND Trials https://thevitalrecord.ai/2026/06/10/listeria-requeson-clover-hill-dairy-recall/ The Vital Record en 2026-06-10T00:00:00.000Z Clover Hill Dairy Recalls Requesón and Soft Ricotta After Listeria Kills One and Hospitalizes Eight in Nine-State Cluster https://thevitalrecord.ai/2026/06/10/mflusiva-vrbpac-mrna-flu-june18-bla/ The Vital Record en 2026-06-10T00:00:00.000Z VRBPAC Convenes June 18 on Moderna's MFLUSIVA — First mRNA Seasonal Influenza BLA Before an FDA Panel https://thevitalrecord.ai/2026/06/10/elecoglipron-oral-glp1-phase2-lancet/ The Vital Record en 2026-06-10T00:00:00.000Z AstraZeneca's Oral GLP-1 Pill Trims 11.8% Body Weight in Phase 2 — Phase 3 Now Enrolling https://thevitalrecord.ai/2026/06/10/new-world-screwworm-new-mexico-second-state/ The Vital Record en 2026-06-10T00:00:00.000Z New World Screwworm Reaches New Mexico as Mexico Halts Live Animal Imports — First U.S. Re-Emergence Since 1966 https://thevitalrecord.ai/2026/06/10/ba322-pediatric-immunity-sars-cov2-preprint/ The Vital Record en 2026-06-10T00:00:00.000Z Preprint: New Sublineage BA.3.2.2 Appears to Sidestep Pediatric Antibodies While Adults Stay Protected https://thevitalrecord.ai/2026/06/10/bd-bactec-fxi-510k-sepsis-clearance/ The Vital Record en 2026-06-10T00:00:00.000Z BD BACTEC FXI Receives 510(k) Clearance, Detecting Sepsis Pathogens About Three Hours Faster Than Its Predecessor https://thevitalrecord.ai/2026/06/09/a-muscle-sparing-antibody-blunted-lean-mass-loss-during-tirzepatide-we/ The Vital Record en 2026-06-09T00:00:00.000Z A muscle-sparing antibody blunted lean-mass loss during tirzepatide weight loss in a phase 2 trial https://thevitalrecord.ai/2026/06/09/sparing-the-muscle-is-not-yet-saving-the-strength/ The Vital Record en 2026-06-09T00:00:00.000Z Sparing the muscle is not yet saving the strength https://thevitalrecord.ai/2026/06/09/bundibugyo-ebola-passes-530-cases-in-drc-and-uganda-at-a-17-4-fatality/ The Vital Record en 2026-06-09T00:00:00.000Z Bundibugyo Ebola passes 530 cases in DRC and Uganda at a 17.4% fatality rate; CDC judges US risk low https://thevitalrecord.ai/2026/06/09/gsk-to-buy-nuvalent-for-10-6-billion-betting-on-two-investigational-lu/ The Vital Record en 2026-06-09T00:00:00.000Z GSK to buy Nuvalent for $10.6 billion, betting on two investigational lung-cancer drugs awaiting FDA decisions https://thevitalrecord.ai/2026/06/09/early-treatment-of-ctdna-positive-colorectal-cancer-did-not-improve-di/ The Vital Record en 2026-06-09T00:00:00.000Z Early treatment of ctDNA-positive colorectal cancer did not improve disease-free survival in the phase 3 ALTAIR trial https://thevitalrecord.ai/2026/06/09/intercept-ends-phase-3-obeticholic-acid-extension-trial-after-fda-with/ The Vital Record en 2026-06-09T00:00:00.000Z Intercept ends Phase 3 obeticholic acid extension trial after FDA withdraws Ocaliva approval https://thevitalrecord.ai/2026/06/09/fda-early-alert-oxygen-blender-shaft-in-ge-healthcare-giraffe-and-pand/ The Vital Record en 2026-06-09T00:00:00.000Z FDA Early Alert: oxygen-blender shaft in GE HealthCare Giraffe and Panda infant resuscitation systems can loosen and misdeliver oxygen https://thevitalrecord.ai/2026/06/09/an-ai-pathology-test-may-flag-which-high-risk-prostate-cancers-benefit/ The Vital Record en 2026-06-09T00:00:00.000Z An AI pathology test may flag which high-risk prostate cancers benefit most from abiraterone https://thevitalrecord.ai/2026/06/09/fda-accepts-a-proposed-entyvio-biosimilar-for-review-interchangeabilit/ The Vital Record en 2026-06-09T00:00:00.000Z FDA accepts a proposed Entyvio biosimilar for review; interchangeability not yet granted https://thevitalrecord.ai/2026/06/09/takeda-halts-soticlestat-phase-3-extension-after-both-pivotal-epilepsy/ The Vital Record en 2026-06-09T00:00:00.000Z Takeda halts soticlestat Phase 3 extension after both pivotal epilepsy trials miss https://thevitalrecord.ai/2026/06/09/in-a-diabetes-trial-a-heart-failure-drug-s-benefit-looked-largest-in-1/ The Vital Record en 2026-06-09T00:00:00.000Z In a diabetes trial, a heart-failure drug's benefit looked largest in 121 patients carrying a cardiomyopathy gene variant — an exploratory signal https://thevitalrecord.ai/2026/06/09/incyte-to-buy-vega-therapeutics-for-up-to-2b-betting-on-a-subcutaneous/ The Vital Record en 2026-06-09T00:00:00.000Z Incyte to buy Vega Therapeutics for up to $2B, betting on a subcutaneous bleeding-disorder antibody still in trials https://thevitalrecord.ai/2026/06/09/vaping-after-quitting-cigarettes-tied-to-higher-lung-cancer-risk-in-4/ The Vital Record en 2026-06-09T00:00:00.000Z Vaping after quitting cigarettes tied to higher lung-cancer risk in 4.5-million-person Korean cohort https://thevitalrecord.ai/2026/06/09/fda-clears-next-gen-gi-genius-colonoscopy-ai-from-medtronic-and-cosmo/ The Vital Record en 2026-06-09T00:00:00.000Z FDA clears next-gen GI Genius colonoscopy AI from Medtronic and Cosmo